TCL Archive Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion. December 2, 2005
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT. April 21, 2000